Can regular use of the Cough Assist machine maintain lung function in children and adolescents with neuromuscular disease?

Completed

• Conditions: neuromuscular disease with diminished lung function; Respiratory - Other respiratory disorders / diseases; Musculoskeletal - Other muscular and skeletal disorders; Neurological - Other neurological disorders

• Registration Number: ACTRN12611000627954
• Lead Sponsor: niversity of Notre Dame Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

neuromuscular disease, under 18 yrs of age, able to provide consent, English speaking,

Exclusion Criteria

ambulant, unable to provide appropriate spirometry measures

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
using the Vitalograph Alpha 6000 spirometer to measure vital capacity (L), peak expiratory flow (L/min) and peak cough flow (L/min) of all participants. This will give an indication of whether lung function is being maintained.[these meaures will be taken monthly over a four month period (March 2011 - June 2011)]

Secondary Outcome Measures

Name	Time	Method
nil[nil]